Archean Chemical Industries Ltd Q4 FY2025 Concall Summary

Key Takeaways

• Volume recovery, not price, drove the quarter: Industrial Salt volumes hit 0.13 crore tons after logistics fixes, while bromine volumes lagged on extended winter but rebounded past budgeted rates by March.
• Bromine Derivatives reached commercial milestone: First ~500 metric tons sold in Q4, with exports underway and utilization at 20-30%, though the segment still runs at a ~₹5 crores PAT loss.
• FY26 is a volume-growth story across segments: Management targets 22,000-25,000 tons of bromine (including captive), 0.45-0.5 crore tons of salt, and a first contribution from Sulphate of Potash in H2.
• New ventures are moving from promise to production: Oren Hydrocarbons expects ₹150 crores in FY26 revenue; the semiconductor land acquisition is complete and awaiting central approval; the zinc-bromide battery pilot plant is advancing toward site selection.
• What to watch next quarter: Whether bromine derivative utilization crosses 50% as guided, the pace of Oren Hydrocarbons' remaining unit commissioning, and any update on the flame retardant project timeline.

Bromine: Volume Ambition Meets Pricing Discipline

• Winter disruption, March catch-up: Extended winter in January-February suppressed evaporation rates and brine concentration, pushing the seasonal volume peak into March; current production rates exceed budgeted levels.
• Demand structurally ahead of supply: Management stated demand consistently exceeds what Archean can supply to its own customers, with infrastructure capable of supporting in excess of 30,000 tons and further enhancement possible through brine efficiency without large expenditure.
• FY26 volume target: Budgeting 22,000 to 25,000 tons of total bromine sales including captive consumption, implying upwards of 20% to 25% volume growth based on existing contracts and visibility, with base demand still unmet.
• Pricing spike was supply-shock driven, not structural: The 70% price jump in a month came from West Asian supply disruptions; management knew the spike would not last and considers planning on spikes unrealistic.
• Long-term contract pricing anchored below spot: If spot stays at \$4, long-term contracts would settle between \$3.25 to \$3.50, reflecting roughly a 20% discount and local duty elements in China; management sees no reason for prices to fall at renewal and notes upside potential.

Pendurthi: "I think market participants and shareholders understand that supply shocks generally only lead to such a rapid increase in price. So I think, that the supply disruptions from West Asia and I think that caused the spike. But in our conversations with customers and as well as we ourselves as a company knew that this spike won't last."

Industrial Salt: Logistics Fix Unlocks Run-Rate

• Operational turnaround delivered: Earlier-quarter logistics challenges were largely addressed through addition of a dedicated own fleet, enabling a solid Q4 recovery with volumes reaching 0.13 crore tons.
• Capacity now above 0.5 crore tons annually: A second washery line was commissioned, taking annual capacity past the 0.5 crore ton mark; management expects quarterly run rates to stay above 0.1 crore tons going forward.
• FY26 volume target: Expecting in excess of 0.4 crore tons, with 0.45 to 0.5 crore tons achievable; management is not overly concerned about hitting the 0.5 crore mark this year.
• Pricing stable with slight softening: Salt prices have been largely stable with perhaps a 5-10% drop, but volume far more than compensates; domestic contracts renewed in recent months came at better prices on a rolling basis.
• Mix shift in Q4: Salt rose to roughly 65% of revenue from around 50% in prior quarters; management views both salt and bromine as important contributors to the bottom line.

Bromine Derivatives: Early Commercialization, Profitability the Next Test

• First commercial sales achieved: Approximately 500 metric tons of Bromine Derivatives were sold in Q4 FY25, with exports starting from the facility and products well received by the market.
• Utilization still ramping: Operations are running at 20-30% capacity utilization; management expects this to rise to more than 50% in the near term.
• Phase 1 completed under budget: The initial phase of the bromine derivative business came in below the original ₹250 crores budget, with the balance ₹80-90 crores allocated to the flame retardant project.
• Profitability not yet achieved: The consolidated-minus-standalone math shows a ~₹5 crores loss on the derivative business at the PAT level; management wants to see a positive PAT figure this year.
• 10,000-ton target still in sight but not committed: Management called the previous FY26 projection of 10,000 metric tons "probably achievable" but wants to see performance stabilize over the next couple of quarters, citing geopolitical changes and oil price movements as variables.
• Realization data withheld: When asked for average realization across derivative products, management declined to answer on the call, with the CFO to follow up post-call.

Pendurthi: "But on a volume basis, I think -- it's not incorrect to say that is it achievable or not, it is probably achievable. But we'd like to see performance happen over the next couple of quarters and stabilize."

New Ventures: Three Bets Moving Toward Revenue

• Oren Hydrocarbons: Two facilities in Andhra Pradesh are now ready; two remaining units in Gujarat and one in Tamil Nadu are likely to commence operations towards the latter part of FY26; management expects approximately ₹150 crores in conservative FY26 revenue, with peak potential much higher given the company touched ~₹500 crores before its earlier troubles.
• Semiconductor initiative: Land acquisition is complete, the project has state-level approval in Orissa, and an application has been submitted to the Indian semiconductor mission; awaiting central approval.
• Energy storage (zinc-bromide battery): Offgrid Energy Labs, the U.S.-based innovator, is advancing site identification and vendor selection for a pilot plant in the U.K.; management hopes this will be finalized and the start-up begun in the coming quarter.
• Sulphate of Potash: Moving to demonstrate at plant scale in the next quarter; meaningful contributions are anticipated starting in the second half of FY26.
• Flame retardant bromine project: Being actively pursued; management would ideally like to commission within FY26 and will provide a better update on the next call; capex of ₹80-90 crores remains within the original ₹250 crores budget.

Costs, Margins & Capital Allocation

• Employee cost reduction: The FY25 decline in employee cost was driven by ESOP utilization and MD submission compared to the prior year.
• Other expenses rose on volume and provisions: The Q4 increase in other expenses was largely due to higher operating expenses from a 55% increase in salt quantity and year-end provisions.
• Derivative margin trajectory: Management cautioned that a 20% margin assumption for this year would not be accurate because investment has to start paying off and utilization has to move up first.
• No large capex outside existing budgets: Salt requires only regular maintenance capex; bromine derivatives are within the original ₹250 crores budget; Oren Hydrocarbons is within a ₹25-30 crores budget; management will revert with specific FY26 and FY27 capex figures.
• Lease renewal in progress: The lease is continuously a work in progress; authorities have assured they will move on it quickly.

Pendurthi: "Yes. So I think on a PAT basis, definitely, we want to see a positive figure this year, for sure."

Guidance & Commitments

Key Metrics